Announcements Trials

Browse Landscape

Status

Completed 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 6 Gastrointestinal 5 Gynecologic 2 Genitourinary 2 Sarcoma 1

Conditions

Soft Tissue Neoplasms 1 Sarcoma 1 Hypersensitivity 1

Interventions

Doxorubicin 25 Radiotherapy 16 apatinib 15 Cyclophosphamide 15 Ifosfamide 13 anlotinib 12 camrelizumab 10 Temozolomide 9 Imatinib Mesylate 9 Vincristine 8 Surgical Procedures, Operative 7 Neoadjuvant Therapy 7 Methotrexate 7 Drug Therapy 7 Dactinomycin 5 Blood Specimen Collection 5 fludarabine phosphate 4 Paclitaxel 4 Immune Checkpoint Inhibitors 4 Etoposide 4 Docetaxel 4 Carboplatin 4 toripalimab 3 pembrolizumab 3 Trabectedin 3 Topotecan 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Nivolumab 3 Melphalan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × High-Energy Shock Waves × Sarcoma × Clear all

NCT02834585 2016-07-15

MUSTT

University of Genova

Hypersensitivity, Sarcoma, Soft Tissue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡